(Q33766318)

29 July 2017

title

Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years (English)

1 reference

29 July 2017

main subject

ankylosing spondylitis

1 reference

Xenofon Baraliakos

1

1 reference

29 July 2017

Hildrun Haibel

2

1 reference

29 July 2017

Claudia Fritz

3

1 reference

29 July 2017

Joachim Listing

4

1 reference

29 July 2017

Frank Heldmann

5

1 reference

29 July 2017

Juergen Braun

6

1 reference

29 July 2017

Joachim Sieper

7

1 reference

29 July 2017

publication date

1 January 2013

1 reference

Arthritis Research and Therapy

29 July 2017

published in

1 reference

29 July 2017

volume

15

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

R67

1 reference

Etanercept in the longterm treatment of patients with ankylosing spondylitis

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER.

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

ASAS/EULAR recommendations for the management of ankylosing spondylitis

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Employment perspectives of patients with ankylosing spondylitis

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Prognosis, course of disease, and treatment of the spondyloarthropathies

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

The MOS 36-ltem Short-Form Health Survey (SF-36)

22 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

22 June 2018

1 reference

Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study

21 January 2018

1 reference

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

21 January 2018

1 reference

Results from an open-label extension study of etanercept in ankylosing spondylitis

21 January 2018

1 reference

Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept

21 January 2018

1 reference

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept

21 January 2018

1 reference

Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.

21 January 2018

1 reference

Analysis of uveitis rates across all etanercept ankylosing spondylitis clinical trials.

21 January 2018

1 reference

Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060369

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

30 October 2018

1 reference

12 December 2020

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha

1 reference

12 December 2020

Predictors of the progression of functional disability in patients with ankylosing spondylitis

1 reference

12 December 2020

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis

1 reference

12 December 2020

Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis

1 reference

12 December 2020

Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period

1 reference

12 December 2020

Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis

1 reference

12 December 2020

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

1 reference

12 December 2020

Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome

1 reference

12 December 2020

Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study

1 reference

12 December 2020

Identifiers

DOI

10.1186/AR4244

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference